From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

City Grandee Sir Nigel Rudd and Destiny Pharma serve up damning critique of AIM as they abandon the casino

By Tom Winnifrith, the Sheriff of AIM | Monday 15 July 2024


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Quite simply, Sir Nigel warns that Destiny Pharma (DEST) will go bust if it stays on AIM. If it delists he reckons it might survive. This is no penny dreadful. Destiny is a properly managed company and Rudd is a well-respected BSD so these words will hurt.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Wednesday »

Bearcast

Tom Winnifrith Bearcast: red flags and bubbles

 

SDI

SDI Group – again a Buy?

 

Tom

Feeling Thirsty Evil Banksta?

Wednesday »

Bearcast

Tom Winnifrith bearcast: these folks are insane

Time left: 00:17:01